{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:09:19Z","timestamp":1793261359941,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T00:00:00Z","timestamp":1500940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T00:00:00Z","timestamp":1500940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fungal peritonitis in a patient on peritoneal dialysis (PD) is a refractory injury accompanied by severe inflammation, predisposing patients to a poor prognosis. Defective clearance of necrotic tissue interferes with amelioration of tissue injury and induces abnormal tissue remodeling. In the recent reports, apoptosis inhibitor of macrophage (AIM, also called CD5L) prevents obesity, hepatocellular carcinoma and acute kidney injury. Here, we investigated potential roles of AIM in prevention of progression of fungal peritonitis models. <jats:italic>AIM<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup> mice subjected to zymosan-induced peritonitis exhibited progressive inflammation and sustained peritoneal necrosis tissue on day 28 after the disease induction, whereas there was an improvement in <jats:italic>AIM<\/jats:italic><jats:sup>+\/+<\/jats:sup> mice. This appeared to be caused by deposition of AIM at the necrotic peritoneum in <jats:italic>AIM<\/jats:italic><jats:sup>+\/+<\/jats:sup> mice. <jats:italic>In vitro<\/jats:italic>, AIM enhanced the engulfment of necrotic debris by macrophages derived from zymosan-induced peritonitis, M1- and M2a-like bone marrow derived macrophages, as well as by mesothelial cells. In addition, administration of recombinant AIM dramatically ameliorated severe inflammation associated with necrosis in zymosan-induced peritonitis of <jats:italic>AIM<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup> mice. Our observations suggest that AIM appears to be involved in the repair process of zymosan-induced peritonitis, and thus, could be the basis of development of new therapeutic strategies for PD-related fungal peritonitis.<\/jats:p>","DOI":"10.1038\/s41598-017-06824-6","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T14:35:55Z","timestamp":1500474955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Apoptosis inhibitor of macrophage ameliorates fungus-induced peritoneal injury model in mice"],"prefix":"10.1038","volume":"7","author":[{"given":"Takako","family":"Tomita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kento","family":"Kitada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiko","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiri","family":"Hiramoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Takei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,25]]},"reference":[{"key":"6824_CR1","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.4049\/jimmunol.0804245","volume":"183","author":"M Mizuno","year":"2009","unstructured":"Mizuno, M. et al. Zymosan, but not lipopolysaccharide, triggers severe and progressive peritoneal injury accompanied by complement activation in a rat peritonitis model. J immunol. \n                           183, 1403\u201312 (2009).","journal-title":"J immunol."},{"key":"6824_CR2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrneph.2013.100","volume":"9","author":"SJ Davies","year":"2013","unstructured":"Davies, S. J. Peritoneal dialysis\u2013current status and future challenges. Nat Rev Nephrol. \n                           9, 399\u2013408 (2013).","journal-title":"Nat Rev Nephrol."},{"key":"6824_CR3","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1681\/ASN.2012030226","volume":"24","author":"H Kinashi","year":"2013","unstructured":"Kinashi, H. et al. TGF-b1 promotes lymphangiogenesis during peritoneal fibrosis. J Am Soc Nephrol. \n                           24, 1627\u201342 (2013).","journal-title":"J Am Soc Nephrol."},{"key":"6824_CR4","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/labinvest.2015.87","volume":"95","author":"T Terabayashi","year":"2015","unstructured":"Terabayashi, T. et al. Vascular endothelial growth factor receptor-3 is a novel target to improve net ultrafiltration in methylglyoxal-induced peritoneal injury. Lab Invest. \n                           95, 1029\u201343 (2015).","journal-title":"Lab Invest."},{"key":"6824_CR5","doi-asserted-by":"publisher","first-page":"F1084","DOI":"10.1152\/ajprenal.00565.2007","volume":"294","author":"H Nishimura","year":"2008","unstructured":"Nishimura, H. et al. Mineralocorticoid receptor blockade ameliorates peritoneal fibrosis in new rat peritonitis model. Am J Physiol Renal Physiol. \n                           294, F1084\u201393 (2008).","journal-title":"Am J Physiol Renal Physiol."},{"key":"6824_CR6","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1681\/ASN.2009070694","volume":"21","author":"O Devuyst","year":"2010","unstructured":"Devuyst, O., Margetts, P. J. & Topley, N. The pathophysiology of the peritoneal membrane. J Am Soc Nephrol. \n                           21, 1077\u201385 (2010).","journal-title":"J Am Soc Nephrol."},{"key":"6824_CR7","doi-asserted-by":"publisher","first-page":"F116","DOI":"10.1152\/ajprenal.00543.2013","volume":"306","author":"S Aoki","year":"2014","unstructured":"Aoki, S. et al. Epithelial-to-mesenchymal transition and slit function of mesothelial cells are regulated by the cross talk between mesothelial cells and endothelial cells. Am J Physiol Renal Physiol. \n                           306, F116\u201322 (2014).","journal-title":"Am J Physiol Renal Physiol."},{"key":"6824_CR8","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/ki.2009.202","volume":"76","author":"R Miles","year":"2009","unstructured":"Miles, R. et al. Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int. \n                           76, 622\u20138 (2009).","journal-title":"Kidney Int."},{"key":"6824_CR9","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1053\/ajkd.2000.19833","volume":"36","author":"AY Wang","year":"2000","unstructured":"Wang, A. Y. et al. Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center. Am J Kidney Dis. \n                           36, 1183\u201392 (2000).","journal-title":"Am J Kidney Dis."},{"key":"6824_CR10","first-page":"77","volume":"22","author":"J Felgueiras","year":"2006","unstructured":"Felgueiras, J. et al. Risk of technique failure and death in fungal peritonitis is determined mainly by duration on peritoneal dialysis: single-center experience of 24 years. Adv Perit Dial. \n                           22, 77\u201381 (2006).","journal-title":"Adv Perit Dial."},{"key":"6824_CR11","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1177\/089686080902900602","volume":"29","author":"EA Brown","year":"2009","unstructured":"Brown, E. A. et al. Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis: position paper for ISPD. Perit Dial Int. \n                           29, 595\u2013600 (2009).","journal-title":"Perit Dial Int."},{"key":"6824_CR12","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/ki.2010.16","volume":"77","author":"DW Johnson","year":"2010","unstructured":"Johnson, D. W. et al. Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes. Kidney Int. \n                           77, 904\u201312 (2010).","journal-title":"Kidney Int."},{"key":"6824_CR13","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0272-6386(04)00953-9","volume":"44","author":"H Kawanishi","year":"2004","unstructured":"Kawanishi, H. et al. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am J Kidney Dis. \n                           44, 729\u201337 (2004).","journal-title":"Am J Kidney Dis."},{"key":"6824_CR14","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/S0272-6386(12)70262-7","volume":"20","author":"R Nagappan","year":"1992","unstructured":"Nagappan, R., Collins, J. F. & Lee, W. T. Fungal peritonitis in continuous ambulatory peritoneal dialysis\u2013the Auckland experience. Am J Kidney Dis. \n                           20, 492\u20136 (1992).","journal-title":"Am J Kidney Dis."},{"key":"6824_CR15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s11255-010-9848-y","volume":"43","author":"K Trigka","year":"2011","unstructured":"Trigka, K. et al. Encapsulating peritoneal sclerosis: a single-center experience and review of the literature. Int Urol Nephrol. \n                           43, 519\u201326 (2011).","journal-title":"Int Urol Nephrol."},{"issue":"Suppl","key":"6824_CR16","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1046\/j.1440-1797.8.s.11.x","volume":"8","author":"HY Lee","year":"2003","unstructured":"Lee, H. Y. et al. Sclerosing encapsulating peritonitis as a complication of long-term continuous ambulatory peritoneal dialysis in Korea. Nephrology (Carlton). \n                           8(Suppl), S33\u20139 (2003).","journal-title":"Nephrology (Carlton)."},{"key":"6824_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.5414\/CNP68125","volume":"68","author":"S Gupta","year":"2007","unstructured":"Gupta, S. & Woodrow, G. Successful treatment of fulminant encapsulating peritoneal sclerosis following fungal peritonitis with tamoxifen. Clin Nephrol. \n                           68, 125\u20139 (2007).","journal-title":"Clin Nephrol."},{"key":"6824_CR18","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s10157-011-0471-8","volume":"15","author":"M Mizuno","year":"2011","unstructured":"Mizuno, M. et al. Peritonitis is still an important factor for withdrawal from peritoneal dialysis therapy in the Tokai area of Japan. Clin Exp Nephrol. \n                           15, 727\u201337 (2011).","journal-title":"Clin Exp Nephrol."},{"key":"6824_CR19","doi-asserted-by":"crossref","unstructured":"Mizuno, M. et al. Recent analysis of status and outcomes of peritoneal dialysis in the Tokai area of Japan: the second report of the Tokai peritoneal dialysis registry. Clin Exp Nephrol. in press (2016).","DOI":"10.1007\/s10157-016-1249-9"},{"key":"6824_CR20","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/089686080502500413","volume":"25","author":"KM Chow","year":"2005","unstructured":"Chow, K. M. et al. A risk analysis of continuous ambulatory peritoneal dialysis-related peritonitis. Perit Dial Int. \n                           25, 374\u20139 (2005).","journal-title":"Perit Dial Int."},{"key":"6824_CR21","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1093\/ndt\/gfm242","volume":"22","author":"SH Han","year":"2007","unstructured":"Han, S. H. et al. Reduced residual renal function is a risk of peritonitis in continuous ambulatory peritoneal dialysis patients. Nephrol Dial Transplant. \n                           22, 2653\u20138 (2007).","journal-title":"Nephrol Dial Transplant."},{"key":"6824_CR22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/089686080702700110","volume":"27","author":"N Prasad","year":"2007","unstructured":"Prasad, N. et al. Impact of nutritional status on peritonitis in CAPD patients. Perit Dial Int. \n                           27, 42\u20137 (2007).","journal-title":"Perit Dial Int."},{"key":"6824_CR23","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1053\/ajkd.2003.50128","volume":"41","author":"Q Wang","year":"2003","unstructured":"Wang, Q., Bernardini, J., Piraino, B. & Fried, L. Albumin at the start of peritoneal dialysis predicts the development of peritonitis. Am J Kidney Dis. \n                           41, 664\u20139 (2003).","journal-title":"Am J Kidney Dis."},{"key":"6824_CR24","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3747\/pdi.2014.00177","volume":"35","author":"HC Pi","year":"2015","unstructured":"Pi, H. C. et al. Serum 25-Hydroxyvitamin D Level Could Predict the Risk for Peritoneal Dialysis-Associated Peritonitis. Perit Dial Int. \n                           35, 729\u201335 (2015).","journal-title":"Perit Dial Int."},{"key":"6824_CR25","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1161\/CIRCRESAHA.113.301198","volume":"113","author":"E Wan","year":"2013","unstructured":"Wan, E. et al. Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction. Circ Res. \n                           113, 1004\u201312 (2013).","journal-title":"Circ Res."},{"key":"6824_CR26","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.4049\/jimmunol.1303195","volume":"192","author":"A Mochizuki","year":"2014","unstructured":"Mochizuki, A. et al. Hepatic stellate cells orchestrate clearance of necrotic cells in a hypoxia-inducible factor-1a-dependent manner by modulating macrophage phenotype in mice. J Immunol. \n                           192, 3847\u201357 (2014).","journal-title":"J Immunol."},{"key":"6824_CR27","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1513\/pats.200605-104SF","volume":"3","author":"PM Henson","year":"2006","unstructured":"Henson, P. M., Vandivier, R. W. & Douglas, I. S. Cell death, remodeling, and repair in chronic obstructive pulmonary disease? Proc Am Thorac Soc. \n                           3, 713\u20137 (2006).","journal-title":"Proc Am Thorac Soc."},{"key":"6824_CR28","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature11714","volume":"493","author":"IJ Juncadella","year":"2013","unstructured":"Juncadella, I. J. et al. Apoptotic cell clearance by bronchial epithelial cells critically influences airway inflammation. Nature. \n                           493, 547\u201351 (2013).","journal-title":"Nature."},{"key":"6824_CR29","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nm.4012","volume":"22","author":"S Arai","year":"2016","unstructured":"Arai, S. et al. Apoptosis inhibitor of macrophage protein enhances intraluminal debris clearance and ameliorates acute kidney injury in mice. Nat Med. \n                           22, 183\u201393 (2016).","journal-title":"Nat Med."},{"key":"6824_CR30","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/1471-213X-10-122","volume":"10","author":"M Sandahl","year":"2010","unstructured":"Sandahl, M. et al. Epithelial cell-directed efferocytosis in the post-partum mammary gland is necessary for tissue homeostasis and future lactation. BMC Dev Biol. \n                           10, 122 (2010).","journal-title":"BMC Dev Biol."},{"key":"6824_CR31","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1242\/jcs.078907","volume":"124","author":"BJ Wagner","year":"2011","unstructured":"Wagner, B. J. et al. Phagocytosis of dying tumor cells by human peritoneal mesothelial cells. J Cell Sci. \n                           124, 1644\u201354 (2011).","journal-title":"J Cell Sci."},{"key":"6824_CR32","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/j.cell.2016.11.047","volume":"167","author":"J Yuan","year":"2016","unstructured":"Yuan, J., Najafov, A. & Py, B. F. Roles of Caspases in Necrotic Cell Death. Cell. \n                           167, 1693\u20131704 (2016).","journal-title":"Cell."},{"key":"6824_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/imr.12534","volume":"277","author":"SM Man","year":"2017","unstructured":"Man, S. M., Karki, R. & Kanneganti, T. D. Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev. \n                           277, 61\u201375 (2017).","journal-title":"Immunol Rev."},{"key":"6824_CR34","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1084\/jem.189.2.413","volume":"189","author":"T Miyazaki","year":"1999","unstructured":"Miyazaki, T. et al. Increased susceptibility of thymocytes to apoptosis in mice lacking AIM, a novel murine macrophage-derived soluble factor belonging to the scavenger receptor cysteine-rich domain superfamily. J Exp Med. \n                           189, 413\u201322 (1999).","journal-title":"J Exp Med."},{"key":"6824_CR35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.cmet.2005.02.002","volume":"1","author":"S Arai","year":"2005","unstructured":"Arai, S. et al. A role for the apoptosis inhibitory factor AIM\/Spalpha\/Api6 in atherosclerosis development. Cell Metab. \n                           1, 201\u201313 (2005).","journal-title":"Cell Metab."},{"key":"6824_CR36","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.cmet.2010.04.013","volume":"11","author":"J Kurokawa","year":"2010","unstructured":"Kurokawa, J. et al. Macrophage-derived AIM is endocytosed into adipocytes and decreases lipid droplets via inhibition of fatty acid synthase activity. Cell Metab. \n                           11, 479\u201392 (2010).","journal-title":"Cell Metab."},{"key":"6824_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.celrep.2014.08.058","volume":"9","author":"N Maehara","year":"2014","unstructured":"Maehara, N. et al. Circulating AIM prevents hepatocellular carcinoma through complement activation. Cell Rep. \n                           9, 61\u201374 (2014).","journal-title":"Cell Rep."},{"key":"6824_CR38","doi-asserted-by":"publisher","first-page":"35391","DOI":"10.1074\/jbc.M505042200","volume":"280","author":"MR Sarrias","year":"2005","unstructured":"Sarrias, M. R. et al. A role for human Sp alpha as a pattern recognition receptor. J Biol Chem. \n                           280, 35391\u20138 (2005).","journal-title":"J Biol Chem."},{"key":"6824_CR39","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cell.2004.09.032","volume":"119","author":"SB Joseph","year":"2004","unstructured":"Joseph, S. B. et al. LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell. \n                           119, 299\u2013309 (2004).","journal-title":"Cell."},{"key":"6824_CR40","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/cmi.2014.12","volume":"11","author":"VG Martinez","year":"2014","unstructured":"Martinez, V. G. et al. The macrophage soluble receptor AIM\/Api6\/CD5L displays a broad pathogen recognition spectrum and is involved in early response to microbial aggression. Cell Mol Immunol. \n                           11, 343\u201354 (2014).","journal-title":"Cell Mol Immunol."},{"key":"6824_CR41","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/978-1-4939-3353-2_4","volume":"1397","author":"M Mizuno","year":"2016","unstructured":"Mizuno, M. & Ito, Y. Rat Models of Acute and\/or Chronic Peritoneal Injuries Including Peritoneal Fibrosis and Peritoneal Dialysis Complications. Methods Mol Biol. \n                           1397, 35\u201343 (2016).","journal-title":"Methods Mol Biol."},{"key":"6824_CR42","doi-asserted-by":"publisher","first-page":"F1245","DOI":"10.1152\/ajprenal.00652.2011","volume":"302","author":"M Mizuno","year":"2012","unstructured":"Mizuno, M. et al. Membrane complement regulators protect against fibrin exudation increases in a severe peritoneal inflammation model in rats. Am J Physiol Renal Physiol. \n                           302, F1245\u201351 (2012).","journal-title":"Am J Physiol Renal Physiol."},{"key":"6824_CR43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s41100-017-0100-4","volume":"3","author":"Y Ito","year":"2017","unstructured":"Ito, Y. et al. Peritonitis-induced peritoneal injury models for research in peritoneal dialysis review of infectious and non-infectious models. Renal Replacement Therapy. \n                           3, 16, doi:10.1186\/s41100-017-0100-4 (2017).","journal-title":"Renal Replacement Therapy."},{"key":"6824_CR44","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","volume":"41","author":"PJ Murray","year":"2014","unstructured":"Murray, P. J. et al. Macrophage Activation and Polarization:Nomenclature and Experimental Guidelines. Immunity. \n                           41, 14\u201320 (2014).","journal-title":"Immunity."},{"key":"6824_CR45","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1096\/fj.14-259341","volume":"29","author":"C Lastrucci","year":"2015","unstructured":"Lastrucci, C. et al. Molecular and cellular profiles of the resolution phase in a damage-associated molecular pattern (DAMP)-mediated peritonitis model and revelation of leukocyte persistence in peritoneal tissues. FASEB J. \n                           29, 1914\u20131929 (2015).","journal-title":"FASEB J."},{"key":"6824_CR46","unstructured":"Azad, A. K., Rajaram, M. V., Schlesinger, L. S. Exploitation of the Macrophage Mannose Receptor (CD206) in Infectious Disease Diagnostics and Therapeutics. J Cytol Mol Biol. 1 (2014)."},{"key":"6824_CR47","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","volume":"15","author":"JJ Weening","year":"2004","unstructured":"Weening, J. J. et al. The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited. J Am Soc Nephrol. \n                           15, 241\u2013250 (2004).","journal-title":"J Am Soc Nephrol."},{"key":"6824_CR48","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1172\/JCI75417","volume":"125","author":"L Yang","year":"2015","unstructured":"Yang, L. et al. KIM-1-mediated phagocytosis reduces acute injury to the kidney. J Clin Invest. \n                           125, 1620\u201336 (2015).","journal-title":"J Clin Invest."},{"key":"6824_CR49","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1172\/JCI34487","volume":"118","author":"T Ichimura","year":"2008","unstructured":"Ichimura, T. et al. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Invest. \n                           118, 1657\u201368 (2008).","journal-title":"J Clin Invest."},{"key":"6824_CR50","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1681\/ASN.2015040405","volume":"27","author":"SR Mulay","year":"2016","unstructured":"Mulay, S. R., Linkermann, A. & Anders, H. J. Necroinflammation in Kidney Disease. J Am Soc Nephrol. \n                           27, 27\u201339 (2016).","journal-title":"J Am Soc Nephrol."},{"key":"6824_CR51","doi-asserted-by":"publisher","first-page":"13","DOI":"10.12703\/P6-13","volume":"6","author":"FO Martinez","year":"2014","unstructured":"Martinez, F. O. & Gordon, S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. \n                           6, 13 (2014).","journal-title":"F1000Prime Rep."},{"key":"6824_CR52","doi-asserted-by":"publisher","first-page":"e1120400","DOI":"10.1080\/21624054.2015.1120400","volume":"5","author":"Z Li","year":"2015","unstructured":"Li, Z. & Zhou, Z. How are necrotic cells recognized by their predators? Worm. \n                           5, e1120400 (2015).","journal-title":"Worm."},{"key":"6824_CR53","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3747\/pdi.2016.00078","volume":"36","author":"PK Li","year":"2016","unstructured":"Li, P. K. et al. ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment. Perit Dial Int. \n                           36, 481\u2013508 (2016).","journal-title":"Perit Dial Int."},{"key":"6824_CR54","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/ki.2008.661","volume":"75","author":"I Sakamoto","year":"2009","unstructured":"Sakamoto, I. et al. Lymphatic vessels develop during tubulointerstitial fibrosis. Kidney Int. \n                           75, 828\u201338 (2009).","journal-title":"Kidney Int."},{"key":"6824_CR55","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/ki.2011.464","volume":"81","author":"Y Suzuki","year":"2012","unstructured":"Suzuki, Y. et al. Transforming growth factor-b induces vascular endothelial growth factor-C expression leading to lymphangiogenesis in rat unilateral ureteral obstruction. Kidney Int. \n                           81, 865\u201379 (2012).","journal-title":"Kidney Int."},{"key":"6824_CR56","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/ndt\/gfr302","volume":"27","author":"H Kato","year":"2012","unstructured":"Kato, H. et al. Atrial natriuretic peptide ameliorates peritoneal fibrosis in rat peritonitis model. Nephrol Dial Transplant. \n                           27, 526\u201336 (2012).","journal-title":"Nephrol Dial Transplant."},{"key":"6824_CR57","doi-asserted-by":"publisher","first-page":"357","DOI":"10.15252\/emmm.201570010","volume":"7","author":"R Strippoli","year":"2015","unstructured":"Strippoli, R. et al. Caveolin-1 deficiency induces a MEK-ERK1\/2-Snail-1-dependent epithelial-mesenchymal transition and fibrosis during peritoneal dialysis. EMBO Mol Med. \n                           7, 357 (2015).","journal-title":"EMBO Mol Med."},{"key":"6824_CR58","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.4049\/jimmunol.1401051","volume":"193","author":"Y Shi","year":"2014","unstructured":"Shi, Y. et al. Pristane-induced granulocyte recruitment promotes phenotypic conversion of macrophages and protects against diffuse pulmonary hemorrhage in Mac-1 deficiency. J Immunol. \n                           193, 5129\u201339 (2014).","journal-title":"J Immunol."},{"key":"6824_CR59","doi-asserted-by":"publisher","first-page":"F721","DOI":"10.1152\/ajprenal.00368.2009","volume":"298","author":"M Mizutani","year":"2010","unstructured":"Mizutani, M. et al. Connective tissue growth factor (CTGF\/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate. Am J Physiol Renal Physiol. \n                           298, F721\u201333 (2010).","journal-title":"Am J Physiol Renal Physiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06824-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06824-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06824-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T07:21:54Z","timestamp":1671780114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06824-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,25]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["6824"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-06824-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,25]]},"assertion":[{"value":"31 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6450"}}